Bibliographie (2362)
Death rate 64% higher with B117 COVID variant, study finds
jeudi, 11 mars 2021 11:37 Écrit par Zouhair SouissiDeath rate 64% higher with B117 COVID variant, study finds – CIDRAP News release: Variant B.1.1.7 of COVID-19 associated with a significantly higher mortality rate, research shows – University of Bristol Original Study: Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study – The BMJ
The post Death rate 64% higher with B117 COVID variant, study finds appeared first on Links Medicus.
State of the Art Review | Severe covid-19 pneumonia: pathogenesis and clinical management
jeudi, 11 mars 2021 11:37 Écrit par Zouhair SouissiSevere covid-19 pneumonia: pathogenesis and clinical management – The BMJ
The post State of the Art Review | Severe covid-19 pneumonia: pathogenesis and clinical management appeared first on Links Medicus.
Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk
jeudi, 11 mars 2021 11:37 Écrit par Zouhair SouissiStudy from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk – Association of Anaesthetists of Great Britain and Ireland Original study: Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study – Anaesthesia Commentary on Twitter Reported by > 100 news […]
The post Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk appeared first on Links Medicus.
![[Press release – not published yet] Monoclonal antibodies reduced hospitalizations and death in Phase 3 trial for early COVID-19](/media/k2/items/cache/5ff2da698b3b76e8cdb9d0576e73d737_M.jpg)
[Press release – not published yet] Monoclonal antibodies reduced hospitalizations and death in Phase 3 trial for early COVID-19
jeudi, 11 mars 2021 11:37 Écrit par Zouhair SouissiPress release: Lilly’s bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19 Commentary: Eli Lilly’s combo therapy for COVID-19 cuts serious illness and death in large study – Reuters
The post [Press release – not published yet] Monoclonal antibodies reduced hospitalizations and death in Phase 3 trial for early COVID-19 appeared first on Links Medicus.
![[Preprint] RECOVERY trial: Convalescent plasma does not improve outcomes in patients admitted to hospital with COVID-19](/media/k2/items/cache/55df0111232e1c4fd8c02e91888d2313_M.jpg)
[Preprint] RECOVERY trial: Convalescent plasma does not improve outcomes in patients admitted to hospital with COVID-19
jeudi, 11 mars 2021 11:37 Écrit par Zouhair SouissiConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv Commentary on Twitter (thread – click for more) RECOVERY Pre-print: Convalescent plasma does not improve survival in patients hospitalised with COVID-19 in this randomised controlled trial involving 11,558 patients:https://t.co/36YZwJNY3Q pic.twitter.com/sKR095n1PC — Martin Landray (@MartinLandray) March 10, […]
The post [Preprint] RECOVERY trial: Convalescent plasma does not improve outcomes in patients admitted to hospital with COVID-19 appeared first on Links Medicus.
Opinion | The Differences Between the Vaccines Matter
mercredi, 10 mars 2021 12:37 Écrit par Zouhair SouissiThe Differences Between the Vaccines Matter – Vox
The post Opinion | The Differences Between the Vaccines Matter appeared first on Links Medicus.
Pregnancy and COVID: what the data say
mercredi, 10 mars 2021 12:37 Écrit par Zouhair SouissiPregnancy and COVID: what the data say – Nature
The post Pregnancy and COVID: what the data say appeared first on Links Medicus.
The role of C-reactive protein as a prognostic marker in COVID-19
mercredi, 10 mars 2021 12:37 Écrit par Zouhair SouissiThe role of C-reactive protein as a prognostic marker in COVID-19 – International Journal of Epidemiology
The post The role of C-reactive protein as a prognostic marker in COVID-19 appeared first on Links Medicus.
Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
mercredi, 10 mars 2021 12:37 Écrit par Zouhair SouissiSingle-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster – The Lancet Original study and news release: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval
The post Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster appeared first on Links Medicus.
M-A: Serological evidence of human infection with SARS-CoV-2
mercredi, 10 mars 2021 12:37 Écrit par Zouhair SouissiSerological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis – The Lancet Global Health Invited Commentary: COVID-19 serosurveys for public health decision making – The Lancet Global Health Commentary on Twitter (thread – click for more) Now out: our systematic review and meta-analysis on seroprevalence surveys for SARS-CoV-2 is now out […]
The post M-A: Serological evidence of human infection with SARS-CoV-2 appeared first on Links Medicus.
